Mitochondrial Delivery of Therapeutic Agents by Amphiphilic DNA Nanocarriers

Miu Shan Chan, Dick Yan Tam, Ziwen Dai, Ling Sum Liu, Jonathan Weng Thim Ho, Man Lee Chan, Di Xu, Man Shing Wong, Chung Tin*, Pik Kwan Lo

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

33 Citations (Scopus)

Abstract

The first example of mitochondrial delivery of the anticancer drug doxorubicin (Dox) is presented by lipid-functionalized DNA nanocages (LNCs). Dox localized in mitochondria induces significant cytotoxicity and cellular apoptosis in MCF-7 compared with Dox localized in lysosomes. These results suggest that LNC has the potential to be an outstanding tool in the treatment of specific organelle-related diseases such as cancers. Delivery of the anticancer drug doxorubicin to mitochondria by lipid-functionalized DNA nanocages (LNCs) is demonstrated for the first time. The results suggest outstanding potential for the use of LNCs as drug nanocarriers in treatments for organelle-specific diseases.

Original languageEnglish
Pages (from-to)770-781
Number of pages12
JournalSmall
Volume12
Issue number6
DOIs
Publication statusPublished - 10 Feb 2016

Scopus Subject Areas

  • Biotechnology
  • Biomaterials
  • General Chemistry
  • General Materials Science

User-Defined Keywords

  • anticancer drugs
  • delivery
  • DNA nanocarriers
  • lipophilic molecules
  • mitochondria

Fingerprint

Dive into the research topics of 'Mitochondrial Delivery of Therapeutic Agents by Amphiphilic DNA Nanocarriers'. Together they form a unique fingerprint.

Cite this